J.P. Morgan discloses dealings in Kangji Medical Holdings privatization

J.P. Morgan Securities PLC, an associate connected with the offeror, has disclosed recent dealings in Kangji Medical Holdings Limited shares as part of the company's privatization by way of scheme of arrangement. The transactions, made for J.P. Morgan Securities PLC's own account, occurred on September 10, 2025.

The disclosures include the issue of two derivatives, categorized as "Other types of products." One derivative, involving 500,000 reference securities, had a maturity/closing out date of October 22, 2026, and a reference price of $8.8384, with a total amount paid of $4,419,195.0000. This transaction resulted in a balance of 7,771,142 securities.

The second derivative involved 278,000 reference securities, with a maturity/closing out date of November 3, 2026, and a reference price of $8.8640. The total amount paid for this transaction was $2,464,200.3400, leading to a resultant balance of 8,049,142 securities. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.